UK firm means to take Tnuva global

Sale struck for over $1 billion, profits may help bail out struggling kibbutzim.

March 6, 2007 22:14
UK firm means to take Tnuva global

Tnuva milk bags 298.88. (photo credit: Ariel Jerozolimski)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

The British-based Apax investment fund has bought a majority stake in Israel's premier agricultural produce firm, Tnuva, for more than $1 billion, Israeli media reported Tuesday. Tnuva has been the flagship of the kibbutz farm movement for eight decades. In recent years, many kibbutzim have fallen on hard times, and some are burdened by huge debts. Sale of Tnuva would help bail them out. The Tnuva trademark is one of Israel's best known, appearing on many dairy products, and the company handles the marketing of most of the produce from Israel's agricultural sector. The reports said Apax plans to turn Tnuva into an international concern.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection